logo

For the Inventor, By the Inventor

Rockville, MD, United States of America

Innovative Cellular Therapeutics, Inc.


USPTO Granted Patents = 15



Forward Citations = 1

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal Chengfei Pu (13 out of 33 patents)

silverMedal Zhiyuan Cao (11 out of 29 patents)

bronzeMedal Lei Xiao (11 out of 13 patents)

4.  Le Tian (7 out of 7 patents)

5.  Zhao Wu (6 out of 28 patents)

6.  Wensheng Wang (5 out of 5 patents)

7.  Xiaogang Shen (5 out of 6 patents)

8.  Wei Ding (4 out of 8 patents)

9.  Dongqi Chen (4 out of 4 patents)

10.  He Sun (3 out of 10 patents)

11.  Lei Xiao (2 out of 24 patents)

12.  Li Mao (2 out of 5 patents)

13.  Christopher Ballas (2 out of 2 patents)

14.  Xianyang Jiang (2 out of 2 patents)

15.  Lei Zhang (2 out of 65 patents)


15 patents:

1. 12760117 - Nanobody Target MSLN and Uses in Chimeric Antigen Receptor Cell Therapy (2026-10-13),
2. 12709737 - Enhanced Chimeric Antigen Receptor Cells in Hypoxic Tumor Microenvironment (2026-08-18),
3. 12708672 - Vaccine and Uses thereof in Cell Therapy (2026-08-18),
4. 12702708 - Presenting cell and use thereof in cell therapy (2026-08-11),
5. 12685774 - CELL/GENE THERAPIES TARGETING MAGE-A4 PEPTIDE (2026-07-21),
6. 12240915 - Chimeric antigen receptor cells for treating solid tumor (2025-03-04),
7. 12150960 - Modified cell expansion and uses thereof (2024-11-26),
8. 12076343 - Engineered safety in cell therapy (2024-09-03),
9. 12043654 - Anti-GCC antibody and CAR thereof for treating digestive system cancer (2024-07-23),
10. 11970548 - Nanobody target GCC and uses in chimeric antigen receptor cell therapy (2024-04-30),
11. 11944645 - Modified cell and use thereof in gene and cell therapy (2024-04-02),
12. 11858977 - Modified TCR and uses thereof (2024-01-02),
13. 11833174 - Modified cell with enhanced functionality and cellular therapy thereof (2023-12-05),
14. 11633427 - Vaccine and uses thereof in cell therapy (2023-04-25),
15. 11161913 - Chimeric antigen receptor cells for treating solid tumor (2021-11-02),
Company Overview
Innovative Cellular Therapeutics, Inc. is a biotechnology company based in Rockville, Maryland, specializing in the development of advanced cellular therapies. The organization focuses on harnessing the potential of immune cells to create innovative treatments for various diseases, including cancer and autoimmune disorders. By leveraging cutting-edge research in immunotherapy and regenerative medicine, Innovative Cellular Therapeutics aims to improve patient outcomes through targeted and effective therapeutic solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

15 Patents

#46 in Rockville, MD

#293 in Maryland

#21,052 in US

#39,921 in the World

Rockville, MD (US)
Rockville, MD, United States of America

Innovative Cellular Therapeutics, Inc.

Forward Citations = 1

18 inventors:

goldMedal Chengfei Pu (13 out of 33 patents)

silverMedal Zhiyuan Cao (11 out of 29 patents)

bronzeMedal Lei Xiao (11 out of 13 patents)

4.  Le Tian (7 out of 7 patents)

5.  Zhao Wu (6 out of 28 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Innovative Cellular Therapeutics, Inc.. Retrieved from https://idiyas.com/company/innovative-cellular-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…